Head down tilt to improve blood flow in stroke patients
Official title: Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke: a Multicenter, Randomised, Proof of Concept, Phase 2a/b Trial in Patients Treated With Mechanical Thrombectomy
Run by University of Milano Bicocca · NCT06297863 · Data updated 2026-11-12
This study is testing if tilting stroke patients' heads down can improve blood flow to their brains and help them recover better before they receive treatment.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 118 (estimated) |
| Sponsor | University of Milano Bicocca Academic / other |
| Locations | 6 sites (Avezzano and 5 other locations) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06297863 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with acute ischemic stroke caused by left or right middle cerebral artery occlusion who are eligible for mechanical thrombectomy.
✕Probably not a fit
Patients with impaired consciousness, severe respiratory issues, or other significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of a head down tilt position (15°) on collateral blood flow in patients experiencing acute ischemic stroke due to middle cerebral artery occlusion. It is a multicenter, randomized, controlled trial comparing this positional therapy against standard positioning before mechanical thrombectomy. The hypothesis is that the head down tilt will enhance collateral circulation, potentially preserving brain tissue and improving outcomes. The study aims to gather data on the efficacy of this approach in increasing the salvageable brain tissue and extending the treatment window for reperfusion therapies.
Why it matters
Potential benefit: If successful, this approach could lead to improved clinical outcomes for stroke patients undergoing mechanical thrombectomy.
How similar studies have gone: Previous studies have shown promising results with similar positional therapies, but this specific approach is novel in the context of acute ischemic stroke.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute ischemic stroke due to left or right MCA occlusion of the M1 segment (excluding occlusion of the internal carotid artery terminus + M1) * Decision to treat with mechanical thrombectomy (with or without intravenous thrombolysis) * Informed consent obtained from patient or patient's next of kin, or emergency consent procedure Exclusion Criteria: * Impaired consciousness, defined as NIHSS score of 2 or 3 of the item 1a (level of consciousness): not alert, requires repeated stimulation or unresponsive. * Vomiting upon stroke onset. * History of glaucoma. * History or imaging findings of intracranial hypertension of any aetiology * Major breath disorders, defined as follows: * oxygen saturation ≤92% in room air at admission * severe chronic obstructive pulmonary disease (COPD) treated with long-term oxygen therapy. * severe heart failure with NYHA class 3 or 4 (breathlessness during ordinary physical activity or at rest). * Severe obesity, defined as body mass index (BMI) \> 35. * Patients participating in another interventional trial that would interfere with this study. * Female patients who are pregnant
Where it's running
-
Fondazione IRCCS San Gerardo dei Tintori Monza
Monza, Italy Recruiting -
Ospedale Civile SS. Nicola e Filippo Avezzano Pronto Soccorso
Avezzano, Italy Not yet recruiting -
Azienda Ospedaliero Universitaria Careggi
Florence, Italy Not yet recruiting -
Azienda Ospedaliera Policlinico Universitario "G. Martino"
Messina, Italy Not yet recruiting -
Azienda Ospedaliero Universitaria Policlinico Umberto I
Roma, Italy Not yet recruiting -
Ospedale Santa Maria della Misericordia
Udine, Italy Not yet recruiting
Study contacts
- Principal investigator: Simone Beretta, MD, PhD — University of Milano Bicocca
- Study coordinator: Simone Beretta, MD, PhD
- Email: simone.beretta@unimib.it
- Phone: +390392333568
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Short-Term outside-in nerve stimulation for acute ischemic stroke
This trial tests whether a 5-day external trigeminal nerve stimulation given after stroke can help more patients recover better than a sham treatment.
-
Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal
This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.
-
Safety of adding NRICM301 to standard care for adults with acute ischemic stroke
This study tests whether adding NRICM301, a traditional Chinese medicine formula, to usual care is safe for adults with acute ischemic stroke.
-
Intracranial Recanalization with LT3001 in Acute Ischemic Stroke
This phase II study tests whether LT3001 given to adults with acute ischemic stroke can help reopen blocked brain arteries.
-
Mobilisation After Endovascular Stroke Treatment
This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.
-
Endovascular therapy plus standard care vs standard care alone for distal and medium vessel strokes
In people with acute ischemic stroke due to distal or medium vessel blockages, this study tests whether adding endovascular treatment to the usual medical care helps improve outcomes compared with medical care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.